MicroRNAs as a tool to aid stratification of colorectal cancer patients and to guide therapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNAs as a tool to aid stratification of colorectal cancer patients and to guide therapy
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 18, Issue 10, Pages 1027-1038
Publisher
Future Medicine Ltd
Online
2017-06-22
DOI
10.2217/pgs-2017-0004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of bevacizumab in solid tumours: A literature based meta-analysis of randomised trials
- (2017) Giandomenico Roviello et al. EUROPEAN JOURNAL OF CANCER
- Function and Clinical Implications of Long Non-Coding RNAs in Melanoma
- (2017) Georg Richtig et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer
- (2017) Yuanming Lu et al. Cancer Biomarkers
- Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer
- (2016) H. Imaoka et al. ANNALS OF ONCOLOGY
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- (2016) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer treatment and survivorship statistics, 2016
- (2016) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- microRNA-497 inhibits invasion and metastasis of colorectal cancer cells by targeting vascular endothelial growth factor-A
- (2016) Yanyan Qiu et al. CELL PROLIFERATION
- MicroRNAs as Regulators, Biomarkers and Therapeutic Targets in the Drug Resistance of Colorectal Cancer
- (2016) Tao Xie et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis
- (2016) Martin Pichler et al. CLINICAL CANCER RESEARCH
- Melanoma addiction to the long non-coding RNA SAMMSON
- (2016) Eleonora Leucci et al. NATURE
- miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells
- (2016) Mads Heilskov Rasmussen et al. Nature Communications
- Predictive Biomarkers in Colorectal Cancer: From the Single Therapeutic Target to a Plethora of Options
- (2016) Daniela Rodrigues et al. Biomed Research International
- The Clinical Significance of MiR-429 as a Predictive Biomarker in Colorectal Cancer Patients Receiving 5-Fluorouracil Treatment
- (2016) Sheng-jian Dong et al. MEDICAL SCIENCE MONITOR
- MicroRNA-204 modulates colorectal cancer cell sensitivity in response to 5-fluorouracil-based treatment by targeting high mobility group protein A2
- (2016) Haijun Wu et al. Biology Open
- H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal Cancer
- (2016) Masahisa Ohtsuka et al. EBioMedicine
- Diagnostic Potential of Cell-Free and Exosomal MicroRNAs in the Identification of Patients with High-Risk Colorectal Adenomas
- (2016) Ryo Uratani et al. PLoS One
- miR-320 enhances the sensitivity of human colon cancer cells to chemoradiotherapy in vitro by targeting FOXM1
- (2015) Lu-Ying Wan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
- (2015) M Pichler et al. BRITISH JOURNAL OF CANCER
- MiR-320e is a novel prognostic biomarker in colorectal cancer
- (2015) L Perez-Carbonell et al. BRITISH JOURNAL OF CANCER
- Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer
- (2015) T F Hansen et al. BRITISH JOURNAL OF CANCER
- MicroRNA-140-5p Inhibits the Progression of Colorectal Cancer by Targeting VEGFA
- (2015) Wenbo Zhang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- MicroRNA-197 influences 5-fluorouracil resistance via thymidylate synthase in colorectal cancer
- (2015) Z. Sun et al. Clinical & Translational Oncology
- A critical role of mir-199a in the cell biological behaviors of colorectal cancer
- (2015) Hua Ye et al. Diagnostic Pathology
- Exploiting a novel miR-519c–HuR–ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer
- (2015) Kenneth K.W. To et al. EXPERIMENTAL CELL RESEARCH
- MiR-199a-5p and miR-375 affect colon cancer cell sensitivity to cetuximab by targeting PHLPP1
- (2015) Paula Mussnich et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Junk DNA and the long non-coding RNA twist in cancer genetics
- (2015) H Ling et al. ONCOGENE
- Genetic markers of recurrence in colorectal cancer
- (2015) Maria Anna Smolle et al. PHARMACOGENOMICS
- Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer
- (2015) Anna Lena Ress et al. Oncotarget
- MicroRNA-130b Promotes Tumor Development and Is Associated with Poor Prognosis in Colorectal Cancer
- (2015) Tommaso Colangelo et al. NEOPLASIA
- Association of MicroRNA-31-5p with Clinical Efficacy of Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer
- (2014) Hisayoshi Igarashi et al. ANNALS OF SURGICAL ONCOLOGY
- MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients
- (2014) M Pichler et al. BRITISH JOURNAL OF CANCER
- MicroRNA-7expression in colorectal cancer is associated with poor prognosis and regulates cetuximab sensitivity viaEGFRregulation
- (2014) Toshinaga Suto et al. CARCINOGENESIS
- MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patients
- (2014) Anna Lena Ress et al. MOLECULAR CARCINOGENESIS
- Tissue MicroRNAs as Predictors of Outcome in Patients with Metastatic Colorectal Cancer Treated with First Line Capecitabine and Oxaliplatin with or without Bevacizumab
- (2014) Mogens K. Boisen et al. PLoS One
- Vascular endothelial growth factor (VEGF) pathway and neuroendocrine neoplasms (NENs): prognostic and therapeutic considerations
- (2014) Omar Abdel-Rahman TUMOR BIOLOGY
- MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer
- (2014) Verena Stiegelbauer WORLD JOURNAL OF GASTROENTEROLOGY
- Changes in Colorectal Carcinoma Genomes under Anti-EGFR Therapy Identified by Whole-Genome Plasma DNA Sequencing
- (2014) Sumitra Mohan et al. PLoS Genetics
- Serum miR-200c Is a Novel Prognostic and Metastasis-Predictive Biomarker in Patients With Colorectal Cancer
- (2013) Yuji Toiyama et al. ANNALS OF SURGERY
- MicroRNA-126 and epidermal growth factor-like domain 7–an angiogenic couple of importance in metastatic colorectal cancer. Results from the Nordic ACT trial
- (2013) T F Hansen et al. BRITISH JOURNAL OF CANCER
- Complex Tumor Genomes Inferred from Single Circulating Tumor Cells by Array-CGH and Next-Generation Sequencing
- (2013) E. Heitzer et al. CANCER RESEARCH
- MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers
- (2013) Xu Qian et al. CELL CYCLE
- MicroRNA Signature in Metastatic Colorectal Cancer Patients Treated With Anti-EGFR Monoclonal Antibodies
- (2013) Federico Cappuzzo et al. Clinical Colorectal Cancer
- Dysregulation of MicroRNA-34a Expression in Colorectal Cancer Inhibits the Phosphorylation of FAK Via VEGF
- (2013) Danhua Zhang et al. DIGESTIVE DISEASES AND SCIENCES
- MicroRNA-221 promotes colorectal cancer cell invasion and metastasis by targeting RECK
- (2013) Jun Qin et al. FEBS LETTERS
- miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor
- (2013) Martin Pichler et al. JOURNAL OF CLINICAL PATHOLOGY
- miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase
- (2013) Yunfei Zhou et al. Molecular Oncology
- Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment
- (2013) J.B. Kjersem et al. Molecular Oncology
- High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer
- (2013) Mads H. Rasmussen et al. Molecular Oncology
- Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7g
- (2013) Junius Salendo et al. RADIOTHERAPY AND ONCOLOGY
- Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis
- (2013) Jens Neumann et al. VIRCHOWS ARCHIV
- Anti-VEGF Therapies in the Clinic
- (2013) K. L. Meadows et al. Cold Spring Harbor Perspectives in Medicine
- Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N-RAS and IRS1
- (2012) Yu Yin et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer
- (2012) Torben Frøstrup Hansen et al. BMC CANCER
- Beyond KRAS mutation status: influence of KRAScopy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients
- (2012) Leonie JM Mekenkamp et al. BMC CANCER
- Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer
- (2012) M Pichler et al. BRITISH JOURNAL OF CANCER
- High Let-7a MicroRNA Levels in KRAS-Mutated Colorectal Carcinomas May Rescue Anti-EGFR Therapy Effects in Patients with Chemotherapy-Refractory Metastatic Disease
- (2012) A. Ruzzo et al. ONCOLOGIST
- The Clinical Significance of MiR-148a as a Predictive Biomarker in Patients with Advanced Colorectal Cancer
- (2012) Masanobu Takahashi et al. PLoS One
- MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
- (2012) Marek Svoboda et al. Radiation Oncology
- MicroRNA profiling predicts survival in anti-EGFR treated chemorefractory metastatic colorectal cancer patients with wild-type KRAS and BRAF
- (2012) Neda Mosakhani et al. Cancer Genetics
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer
- (2011) Yanlei Ma et al. GUT
- A Specific miRNA Signature Correlates With Complete Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
- (2011) Giuseppina Della Vittoria Scarpati et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil: Is it time to move forward?
- (2010) Shayna L. Showalter et al. CANCER BIOLOGY & THERAPY
- The VEGF family in cancer and antibody-based strategies for their inhibition
- (2010) Laura A. Sullivan et al. mAbs
- Specific Alterations of MicroRNA Transcriptome and Global Network Structure in Colorectal Carcinoma after Cetuximab Treatment
- (2010) M. Ragusa et al. MOLECULAR CANCER THERAPEUTICS
- Role of miR-143 targeting KRAS in colorectal tumorigenesis
- (2009) X Chen et al. ONCOGENE
- MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
- (2008) Aaron J. Schetter et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now